JP2022506272A5 - - Google Patents
Info
- Publication number
- JP2022506272A5 JP2022506272A5 JP2021523494A JP2021523494A JP2022506272A5 JP 2022506272 A5 JP2022506272 A5 JP 2022506272A5 JP 2021523494 A JP2021523494 A JP 2021523494A JP 2021523494 A JP2021523494 A JP 2021523494A JP 2022506272 A5 JP2022506272 A5 JP 2022506272A5
- Authority
- JP
- Japan
- Prior art keywords
- animal
- gastrointestinal barrier
- permeability
- oligosaccharide preparation
- nutritional composition
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023211209A JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862757500P | 2018-11-08 | 2018-11-08 | |
| US201862757465P | 2018-11-08 | 2018-11-08 | |
| US62/757,465 | 2018-11-08 | ||
| US62/757,500 | 2018-11-08 | ||
| PCT/US2019/060443 WO2020097446A1 (en) | 2018-11-08 | 2019-11-08 | Methods of supporting gastrointestinal homeostasis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211209A Division JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022506272A JP2022506272A (ja) | 2022-01-17 |
| JP2022506272A5 true JP2022506272A5 (https=) | 2022-08-23 |
| JPWO2020097446A5 JPWO2020097446A5 (https=) | 2022-08-23 |
| JP7426548B2 JP7426548B2 (ja) | 2024-02-02 |
Family
ID=70612501
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523494A Active JP7426548B2 (ja) | 2018-11-08 | 2019-11-08 | 胃腸の恒常性を支持する方法 |
| JP2023211209A Active JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211209A Active JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12251391B2 (https=) |
| EP (2) | EP4162808A1 (https=) |
| JP (2) | JP7426548B2 (https=) |
| KR (2) | KR102905799B1 (https=) |
| CN (2) | CN113631046B (https=) |
| AU (1) | AU2019376144B2 (https=) |
| BR (1) | BR112021008710A2 (https=) |
| CA (1) | CA3116021A1 (https=) |
| MX (1) | MX2021005374A (https=) |
| WO (1) | WO2020097446A1 (https=) |
| ZA (1) | ZA202102834B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6722697B2 (ja) | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| EP4162808A1 (en) * | 2018-11-08 | 2023-04-12 | DSM IP Assets B.V. | Methods of supporting gastrointestinal homeostasis |
| BR112023001738A2 (pt) * | 2020-08-12 | 2023-03-07 | Zivo Bioscience Inc | O uso de micróbios variovorax como tratamento alternativo para coccidiose |
| EP4255938A1 (en) * | 2020-12-03 | 2023-10-11 | DSM IP Assets B.V. | Oligosaccharide formulation |
| CN116528688A (zh) * | 2020-12-03 | 2023-08-01 | 帝斯曼知识产权资产管理有限公司 | 寡糖制剂 |
| WO2022175263A2 (en) * | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Methods of selectively promoting animal welfare through modulation of microbiome |
| WO2023110658A1 (en) * | 2021-12-13 | 2023-06-22 | Dsm Ip Assets B.V. | Use of oligosaccharide preparation to increase performance of animal vaccinated against coccidiosis |
| CN118804687A (zh) * | 2022-03-09 | 2024-10-18 | 帝斯曼知识产权资产管理有限公司 | 使用寡糖制备物改善蛋禽的性能 |
| EP4561588A1 (en) * | 2022-07-29 | 2025-06-04 | DSM IP Assets B.V. | Reducing necrotic enteritis effect in a bird using an oligosaccharide preparation |
| CN115944033B (zh) * | 2022-12-12 | 2025-05-02 | 中国水产科学研究院黄海水产研究所 | 5-hmf在黄条鰤促生长和提高免疫力饲料添加剂及饲料中应用 |
| CN116350642B (zh) * | 2023-02-28 | 2025-10-17 | 中南民族大学 | 1,6-脱水-β-D-葡萄糖制备用于维持结肠上皮屏障和隐窝的完整性以及抗结肠炎的药品的应用 |
| CN120897746A (zh) * | 2023-04-05 | 2025-11-04 | 帝斯曼知识产权资产管理有限公司 | 对抗呼吸系统疾病作用的寡糖制剂 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10104055A1 (de) | 2001-01-31 | 2002-08-14 | Suedzucker Ag | Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren |
| RU2450815C2 (ru) * | 2005-12-16 | 2012-05-20 | Н.В. Нютрисиа | Применение растворимых пищевых волокон против мышечной атрофии |
| CN102036670A (zh) * | 2007-02-01 | 2011-04-27 | 爱默思公司 | 用于减轻哺乳动物炎症和氧化应激反应的方法 |
| ES2304223B2 (es) | 2007-03-08 | 2009-05-01 | Universidad De Sevilla | Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion. |
| KR101258902B1 (ko) | 2008-12-31 | 2013-05-07 | 엘지디스플레이 주식회사 | 프리즘시트, 이를 구비한 백라이트장치 및 액정표시소자 |
| GB0915315D0 (en) | 2009-09-03 | 2009-10-07 | Univ Manchester | Use of non-digestible oligosaccharides |
| RU2440121C2 (ru) * | 2009-09-23 | 2012-01-20 | Александр Владимирович Диковский | Ветеринарная фармацевтическая композиция и способ (варианты) профилактики и лечения заболеваний жкт и интоксикаций различной этиологии у животных |
| CN102091089A (zh) | 2010-11-22 | 2011-06-15 | 国家海洋局第一海洋研究所 | 一种活性牛蒡寡糖在水产养殖中的应用 |
| CA2864086C (en) | 2011-02-28 | 2018-07-10 | Midori Renewables, Inc. | Polymeric acid catalysts and uses thereof |
| EP2888044A4 (en) | 2012-08-24 | 2016-05-04 | Midori Usa Inc | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGING CELLULOSIC MATERIALS USING SAID CATALYSTS |
| JP6722697B2 (ja) | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| US9492473B2 (en) | 2015-01-26 | 2016-11-15 | Kaleido Biosciences, Inc. | Glycan therapeutics and related methods thereof |
| IL243707A0 (en) * | 2016-01-20 | 2016-05-01 | Galmed Res And Dev Ltd | Treatment to regulate the microbiota in the intestine |
| ES2671175B1 (es) * | 2016-11-18 | 2019-03-13 | Univ Granada | Procedimiento de preparacion de caramelos con elevado contenido en oligosacaridos prebioticos |
| US11278558B2 (en) * | 2017-03-01 | 2022-03-22 | Glycom A/S | Synthetic composition for microbiota modulation |
| CN107897512A (zh) | 2017-11-30 | 2018-04-13 | 河南普尼尔生物制药有限公司 | 一种用于改善鸡肠道健康的肠道保健剂及其制备方法 |
| EP4162808A1 (en) * | 2018-11-08 | 2023-04-12 | DSM IP Assets B.V. | Methods of supporting gastrointestinal homeostasis |
-
2019
- 2019-11-08 EP EP22211012.4A patent/EP4162808A1/en active Pending
- 2019-11-08 JP JP2021523494A patent/JP7426548B2/ja active Active
- 2019-11-08 EP EP19882420.3A patent/EP3876750A4/en active Pending
- 2019-11-08 CA CA3116021A patent/CA3116021A1/en active Pending
- 2019-11-08 KR KR1020217017142A patent/KR102905799B1/ko active Active
- 2019-11-08 KR KR1020257043137A patent/KR20260009387A/ko active Pending
- 2019-11-08 US US17/291,481 patent/US12251391B2/en active Active
- 2019-11-08 WO PCT/US2019/060443 patent/WO2020097446A1/en not_active Ceased
- 2019-11-08 MX MX2021005374A patent/MX2021005374A/es unknown
- 2019-11-08 BR BR112021008710-9A patent/BR112021008710A2/pt active Search and Examination
- 2019-11-08 CN CN201980087791.7A patent/CN113631046B/zh active Active
- 2019-11-08 CN CN202511206955.7A patent/CN121058782A/zh active Pending
- 2019-11-08 AU AU2019376144A patent/AU2019376144B2/en active Active
-
2021
- 2021-04-28 ZA ZA2021/02834A patent/ZA202102834B/en unknown
-
2023
- 2023-12-14 JP JP2023211209A patent/JP7699647B2/ja active Active
-
2024
- 2024-11-15 US US18/949,971 patent/US20250073253A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022506272A5 (https=) | ||
| Hashmat et al. | Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats | |
| Ferenczi et al. | Oligomannan prebiotic attenuates immunological, clinical and behavioral symptoms in mouse model of inflammatory bowel disease | |
| JP2022506148A5 (https=) | ||
| Adams et al. | Efficacy of albendazole against the whipworm Trichuris trichiura-a randomised, controlled trial | |
| CN110475551A (zh) | 使用短链脂肪酸治疗和预防疾病和障碍 | |
| Chang et al. | The suppressive effects of geniposide and genipin on Helicobacter pylori infections in vitro and in vivo | |
| JP2017531673A5 (https=) | ||
| JPWO2020097446A5 (https=) | ||
| JP2017526697A5 (https=) | ||
| JP2019528285A5 (https=) | ||
| Rahman et al. | Chitosan protects immunosuppressed mice against Cryptosporidium parvum infection through TLR4/STAT1 signaling pathways and gut microbiota modulation | |
| WO2018200356A1 (en) | Treating and preventing kidney damage | |
| Schnepf et al. | Rotavirus susceptibility of antibiotic-treated mice ascribed to diminished expression of interleukin-22 | |
| KR20130031229A (ko) | 메포민을 포함하는 자가면역질환 예방 및 치료용 조성물 | |
| Xu et al. | Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide | |
| Kotková et al. | The course of infection caused by Encephalitozoon cuniculi genotype III in immunocompetent and immunodeficient mice | |
| Kogut et al. | BT cationic peptides: Small peptides that modulate innate immune responses of chicken heterophils and monocytes | |
| Ha et al. | Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections | |
| Caniglia et al. | Septic funiculitis caused by S treptococcus equi subspecies equi infection with associated immune‐mediated haemolytic anaemia | |
| Tran et al. | Current and novel treatments for ulcerative colitis | |
| JP2009149572A (ja) | ソバスプラウトの溶媒抽出物およびその組成物 | |
| JP2007504097A5 (https=) | ||
| Wimsatt et al. | Long-term and per rectum disposition of clarithromycin in the desert tortoise (Gopherus agassizii) | |
| Amadori et al. | Constitutive expression of interferons in swine leukocytes |